Brief: Neuland Laboratories Gets 3 Form 483 Observations After FDA Inspection At Unit 3
26/05/2023 12:59
May 26 (Reuters) - Neuland Laboratories Ltd NEUL.NS :
* US FDA INSPECTED UNIT 3 MANUFACTURING FACILITY AT
GADDAPOTHARAM
VILLAGE FROM MAY 22-26
* INSPECTION CONCLUDED WITH 3 OBSERVATIONS (MINOR) UNDER
FORM 483,
RELATING TO PROCEDURES
* INITIATED CORRECTIVE, PREVENTIVE ACTIONS FOR OBSERVATIONS
Further company coverage: NEUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees